Quipt Home Medical (QIPT) Stock Price, News & Analysis

Company Overview

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.

Key Stats

• Today's Range: $2.15 to $2.23
• 50-Day Range: $2.20 to $3.23
• 52-Week Range: $2.15 to $4.23
• Volume: 188,186 shs
• Average Volume: 196,313 shs
• Market Capitalization: $94.80 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $6.25
• Consensus Rating: Buy

Quipt Home Medical Stock Analysis - MarketRank™

Quipt Home Medical scored higher than 39% of companies evaluated by MarketBeat, and ranked 658th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Quipt Home Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Quipt Home Medical has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Decreasing

Earnings Growth

Earnings for Quipt Home Medical are expected to decrease in the coming year, from ($0.05) to ($0.13) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Quipt Home Medical is -12.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Quipt Home Medical is -12.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Quipt Home Medical has a P/B Ratio of 0.89. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.93% of the float of Quipt Home Medical has been sold short.

Short Interest Ratio / Days to Cover

Quipt Home Medical has a short interest ratio ("days to cover") of 8.

Change versus previous month

Short interest in Quipt Home Medical has recently decreased by 2.60%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Quipt Home Medical does not currently pay a dividend.

Dividend Growth

Quipt Home Medical does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

3.93% of the float of Quipt Home Medical has been sold short.

Short Interest Ratio / Days to Cover

Quipt Home Medical has a short interest ratio ("days to cover") of 8.

Change versus previous month

Short interest in Quipt Home Medical has recently decreased by 2.60%, indicating that investor sentiment is improving.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

MarketBeat Follows

2 people have added Quipt Home Medical to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Quipt Home Medical insiders have not sold or bought any company stock.

Percentage Held by Insiders

13.40% of the stock of Quipt Home Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

42.85% of the stock of Quipt Home Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

QIPT Stock Analysis - Frequently Asked Questions

How have QIPT shares performed this year?

Quipt Home Medical's stock was trading at $3.05 at the beginning of the year. Since then, QIPT shares have decreased by 27.9% and is now trading at $2.20.
View the best growth stocks for 2025 here.

How were Quipt Home Medical's earnings last quarter?

Quipt Home Medical Corp. (NASDAQ:QIPT) announced its quarterly earnings data on Monday, February, 10th. The company reported ($0.03) earnings per share (EPS) for the quarter. Quipt Home Medical had a negative trailing twelve-month return on equity of 6.70% and a negative net margin of 2.90%.

How do I buy shares of Quipt Home Medical?

Shares of QIPT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Quipt Home Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Quipt Home Medical investors own include Invesco QQQ (QQQ), SPDR S&P 500 ETF Trust (SPY), SPDR Dow Jones Industrial Average ETF Trust (DIA), Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD) and Tesla (TSLA).

Company Calendar

• Last Earnings: 2/10/2025
• Today: 4/04/2025
• Next Earnings (Estimated): 5/13/2025
• Fiscal Year End: 9/30/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Miscellaneous health & allied services, not elsewhere classified
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:QIPT
• CIK: 1540013
• Web: www.protechhomemedical.com
• Phone: 859-878-2220
• Fax: N/A
• Employees: 800
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $6.25
• High Stock Price Target: $9.50
• Low Stock Price Target: $2.50
• Potential Upside/Downside: +184.1%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 6 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($0.17)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-6,760,000.00
• Net Margins: -2.90%
• Pretax Margin: -2.57%
• Return on Equity: -6.70%
• Return on Assets: -2.94%

Debt

• Debt-to-Equity Ratio: 0.74
• Current Ratio: 1.22
• Quick Ratio: 0.87

Sales & Book Value

• Annual Sales: $244.72 million
• Price / Sales: 0.39
• Cash Flow: $0.86 per share
• Price / Cash Flow: 2.56
• Book Value: $2.47 per share
• Price / Book: 0.89

Miscellaneous

• Outstanding Shares: 43,091,000
• Free Float: 37,317,000
• Market Cap: $94.80 million
• Optionable: Optionable
• Beta: 0.61